The global sports nutrition market size was valued at USD 45.24 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2030. Nutrition and diet are essential for maximum performance. Increasing adoption of sedentary lifestyle and growing co... Read More »
November 2023The Mexico hemp CBD market size was valued at USD 11.3 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 26.1% from 2023 to 2030. Favorable government policies that contributed to the increasing adoption of hemp-derived products and the growing acceptance... Read More »
October 2023The global hair growth supplement and treatment market size was estimated at USD 7.74 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.15% from 2024 to 2030. The market is witnessing a significant boost due to the increasing prevalence of hair loss dis... Read More »
October 2023The global precision medicine market size was valued at USD 71.29 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.7% from 2023 to 2030. Diagnostic and therapeutic precision medicines are among the most complex and helpful achievements of current scie... Read More »
October 2023The global myasthenia gravis treatment market size was valued at USD 2.01 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.0% from 2023 to 2030. The key factors driving this market include the rising adoption of immunotherapies, the approval of prom... Read More »
October 2023The global atopic dermatitis drugs market size was valued at USD 14.19 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 8.4% from 2023 to 2030. The growing prevalence of atopic dermatitis, strong pipeline, emergence of biologics, and untapped opportun... Read More »
October 2023The global idiopathic thrombocytopenic purpura therapeutics market size was valued at USD 622.6 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.0% from 2023 to 2030. The prevalence of idiopathic thrombocytopenic purpura (ITP) has been rising, leading ... Read More »
October 2023The global erectile dysfunction drugs market size was valued at USD 2.46 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 8.8% from 2023 to 2030. There is a growing demand for erectile dysfunction (ED) drugs owing to the adoption of a sedentary lifest... Read More »
October 2023The global liver cancer drug market size was valued at USD 2.44 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 15.3% from 2023 to 2030. The extensive availability of novel drugs, a strong drug development pipeline, and rising public awareness regard... Read More »
October 2023The Europe active pharmaceutical ingredients (API) market size was estimated at USD 42.64 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.75% from 2023 to 2030. The market is primarily driven by advancements in developing active pharmaceutical ingredi... Read More »
October 2023The global human immunodeficiency virus therapeutics market size was valued at USD 10.33 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 1.5% from 2023 to 2030. Key drivers for market growth include an increase in HIV infection cases, particularly ... Read More »
October 2023The global glioblastoma multiforme treatment market size was valued at USD 2.46 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.7% from 2023 to 2030. The growing prevalence of glioblastoma multiforme, increasing R&D expenditure, and favorable r... Read More »
September 2023The global rat model market size was valued at USD 1.32 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.06% from 2023 to 2030. The growth of the market is attributed to a rise in the demand for medicines, which has facilitated the increase in research... Read More »
September 2023The global opioid market size was valued at USD 22.8 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 1.4% from 2023 to 2030. Increasing approval and the launch of new opioid medicines to treat patients with chronic pain are the factors expected to dr... Read More »
September 2023The global inhalable drugs market size was valued at USD 31.5 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2030. The increasing prevalence of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and cys... Read More »
September 2023The global plasma protein therapeutics market size was estimated at USD 28.2 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. Approval of plasma products across multiple indications, increasing R & D activities, and high de... Read More »
September 2023The global sarcoma drugs market size was valued at USD 1,287 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.9% from 2023 to 2030. Soaring adoption of novel drugs, the presence of a strong developmental pipeline, the rising incidence of sof... Read More »
September 2023The Asia Pacific nutritional supplements market size was valued at USD 149.4 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030. Asia Pacific has been one of the forerunners in the nutritional supplements market. The population ac... Read More »
September 2023The global ovarian cancer drugs market size was estimated at USD 3.37 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2030. The rising incidence of ovarian cancer owing to the growing unhealthy lifestyles is one of the key factors d... Read More »
September 2023The global small volume parenteral market size was estimated at USD 168.0 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030. The demand for small-volume parenteral (SVPs) has steadily risen due to the increasing prevalence of chron... Read More »
September 2023